Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Follow-up testing at 6-8 weeks and 12-16 weeks allows monitoring of metabolic parameters and ensures the peptide is not producing unexpected effects
Key Takeaways on AOD 9604 Investigational status: AOD 9604 is not an FDA-approved medication for fat loss or any other indication, which is why medical supervision is essential
will carefully monitor your progress with regular lab work and symptom check-ins
Evidence boundary The largest Phase 2b trial used oral dosing for 24 weeks and did not show statistically significant weight loss versus placebo
This helps make sure treatment works well
US$ 26.06
US$ 22.78
US$ 29.61
US$ 23.99
